Navigation Links
AnaptysBio Announces New Strategic Antibody Discovery
Date:1/6/2012

SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances with two partners: Novartis and an undisclosed second pharmaceutical company.    The strategic alliance announced today with Novartis is AnaptysBio's second collaboration with the Swiss-based pharmaceutical company and follows an initial partnership where AnaptysBio successfully delivered antibody candidates for Novartis' development pipeline. 

(Logo: http://photos.prnewswire.com/prnh/20111205/SF16052LOGO)

Under the terms of each alliance, AnaptysBio will utilize its proprietary SHM-XEL platform for the discovery and maturation of novel therapeutic antibodies to multiple oncology-related therapeutic targets.  Each pharmaceutical partner will receive worldwide rights to develop and commercialize a limited number of antibodies against each therapeutic target generated by AnaptysBio.   In addition to an upfront payment and resource-based compensation, AnaptysBio is eligible to receive milestone payments and royalties associated with the development and sale of any products derived from these alliances.

AnaptysBio's proprietary SHM-XEL platform, which couples fully human antibody libraries with in vitro somatic hypermutation (SHM) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies.  By harnessing the natural mechanism of antibody maturation under controlled conditions, SHM-XEL allows for the selection of optimal antibody properties such as high affinity, functionality, cross-reactivity and epitope diversity.  The use of mammalian cell display permits AnaptysBio to optimize manufacturing-related parameters by selecting for high-level expression
'/>"/>

SOURCE AnaptysBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
2. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
3. AtheroNova Announces a New Board Member
4. RSB Spine, LLC Announces 2011 Revenue Growth
5. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
6. Telik Announces Presentation and Webcast at 5th Annual OneMedForum Conference
7. Verify Brand™ Announces the Release of VB Enterprise 4.0
8. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
9. NeoStem Announces Participation in Multiple January Conferences
10. Bionovo Announces $5 Million Financing
11. Amsterdam Molecular Therapeutics Announces € 2.5 Million Equity Raise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Israel , September 2, 2015 ... intent of the National Institute of Allergy and Infectious Diseases ... within the Department of Health and Human Services (HHS), to ... the United States in the 2015-16 ... flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which ...
(Date:9/2/2015)... Whitehouse, NJ (PRWEB) , ... September 02, 2015 ... ... key Technical Services Staff members will be attending Pharma Ed Resources upcoming ... and respected group of industry leading speakers, this timely conference will provide Updates ...
(Date:9/2/2015)... Telford, England (PRWEB) , ... September 02, 2015 ... ... for drug discovery and life science research, today unveiled Genedata Screener ® ... platform for all in-vitro screening brings to market a rich set of new ...
(Date:9/1/2015)... 1, 2015 The American Brain Tumor Association ... its Discovery Research Grant program. LOIs are due no ... CDT. Discovery Grants are one-year, $50,000 grants ... to change current diagnostic or treatment paradigms for adults ... novel research at its earliest stages, in the hopes ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2
... increasingly widespread - moving out from behind the four ... their own purposes to become a cheaper, more available ... pockets of development virtually everywhere, says Prof. Raj Veeramani, ... University of Wisconsin-Madison . , ,From a ...
... Microsoft chairman and chief software architect Bill Gates talked ... industry when he stopped in their classroom during his ... included in the tour, which is promoting greater youth ... Communications. Photo by Jeff Miller , ...
... - Trying to find a vaccine for AIDS is ... different places on a sprawling university campus, it's downright daunting. ... Research Laboratory opened on Sept. 16, the prospects for eventual ... focusing on a technique that may hold greater promise to ...
Cached Biology Technology:RFID technology is opportunity for Wisconsin companies 2RFID technology is opportunity for Wisconsin companies 3RFID technology is opportunity for Wisconsin companies 4RFID technology is opportunity for Wisconsin companies 5RFID technology is opportunity for Wisconsin companies 6RFID technology is opportunity for Wisconsin companies 7RFID technology is opportunity for Wisconsin companies 8Gates displays software's future to UW-Madison students 2Gates displays software's future to UW-Madison students 3Gates displays software's future to UW-Madison students 4New digs for UW AIDS researchers 2
(Date:9/2/2015)... 2, 2015 Biometric ... in a system which uses identical human characteristic ... vein, DNA and finger print. Increasing number of ... such system which provides high level of security. ... and tokens are vulnerable to attacks. Furthermore, Biometric ...
(Date:8/31/2015)... August 31, 2015 Growing need ... in government digitization projects to drive India ... published TechSci Research report, " India Biometrics Market Forecast & ... is projected to grow at a CAGR of over ... anticipated on account of extensive use of biometric technology in ...
(Date:8/28/2015)... , August 28, 2015 ... and Training Market by Assessment Type (Pen & Paper ... Brain Training, Corporate Learning, Academic Research), Vertical and Region ... Assessment and Training Market to grow from USD 2.4 ... at a Compound Annual Growth Rate (CAGR) of 25.6% ...
Breaking Biology News(10 mins):Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 2Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 3Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 4India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4
... Research and Markets ( http://www.researchandmarkets.com/research/7gqfnv/dna_microarray ) has ... A Focus on Sales Growth" report to their ... Microarray 2013 presents the findings of a global market ... buyers and end-users in this field. With a focus ...
... research team led by pediatric blood and marrow transplantation experts ... Masonic Cancer Center, University of Minnesota, have discovered a remarkable ... of patients with the skin disease epidermolysis bullosa. The ... and highlighted in the most recent issue of Nature ...
... mainstay of treatment for patients with end-stage liver disease, the ... new research from the Icahn School of Medicine at Mount ... today, suggests that it may one day become possible ... liver disease. Investigators discovered that a human embryonic stem cell ...
Cached Biology News:DNA Microarray 2013 Market Report: A Focus on Sales Growth 2U of M researchers find novel gene correction model for epidermolysis bullosa 2Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration 2
Mouse polyclonal antibody raised against a partial recombinant MHC2TA. NCBI Entrez Gene ID = 4261...
Mouse monoclonal antibody raised against a partial recombinant NR4A2. NCBI Entrez Gene ID = NR4A2...
... Sight DS-L2 imaging controller is a successor ... and allows users to comfortably observe, record ... controller features an 8.4 inch LCD (XGA) ... of Nikon cameras including the DS-Fi1 , ...
... DNA Technologies also offers a DNA sequencing ... templates including plasmids, PCR products, BACs, etc. ... templates such as purified plasmids or purified ... handling robotics optimized for automated reaction setup ...
Biology Products: